TrialPath
← Back to searchRecruiting

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

NCT07447089 · Università Cattolica di Milano
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Combination of the EMDR Integrative Group Protocol and Individual EMDR Treatment in Patients With Advanced Thyroid Cancer: A Pilot Study
About this study
The diagnosis of cancer represents a potentially life-threatening event that can be considered a unique traumatic stressor. A cancer diagnosis can disrupt a person's life, affecting emotions, cognition, and physical pain impacting the individual sense of identity. Findings from the literature suggest that EMDR can be a valid treatment in the processing of cancer-related traumatic events. With this proposal, the investigators aim to evaluate the feasibility and the effects of a combined EMDR Integrative Group Treatment Protocol and an optional EMDR individual protocol for people with cancer.
Eligibility criteria
Inclusion Criteria: * cancer diagnosis * PTSD (IES-R \> 32) Exclusion Criteria: * receiving specialized trauma therapy * receiving current psychiatric pharmacological treatment, unless the dosage has been stable for at least 2 months prior to enrollment
Study design
Enrollment target: 25 participants
Allocation: na
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2025-12-05
Estimated completion: 2026-12-05
Last updated: 2026-03-04
Interventions
Behavioral: EMDR-IGTP-OTS
Primary outcomes
  • Impact of Event Scale-Revised (IES-R) (Baseline (T1) and Post-intervention (T2, approximately 1 month), Follow-up (T3, approximately 3 month))
Sponsor
Università Cattolica di Milano · other
With: ASST Santi Paolo e Carlo
Contacts & investigators
ContactCesare Cavalera · contact · cesarem.cavalera@unicatt.it · +393409373408
All locations (1)
Università Cattolica del Sacro CuoreRecruiting
Milan, Italy
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study · TrialPath